Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-25 @ 4:08 AM
NCT ID:
NCT06687720
Brief Summary:
This is an open-label, two-arm, prospective, interventional, in-use safety and efficacy study of an oral probiotic supplementation in adult subjects having irritable bowel syndrome.
Detailed Description:
A total of the up to 18 adults aged between 18 and 60 years, with irritable bowel syndrome will be enrolled to ensure 16 subjects complete the study.
Subjectsshall be instructed to visit the facility for the following scheduled visits:
* Visit 01 \[Within 30 days\]: Screening, Blood Parameter Assessment.
* Visit 02 \[Day 01\]: Enrolment, Evaluations, Treatment Dispensing.
* Visit 03 \[Day 15 (±2 days)\]: Telephonic follow-up.
* Visit 04 \[Day 30 (±2 days)\]: Treatment End, Final Evaluations.
Study:
NCT06687720
Study Brief:
Protocol Section:
NCT06687720